

EQRx, a Cambridge, Massachusetts-based drug company, has raised $200 million in Series A funding. The investors included GV, ARCH Venture Partners, Andreessen Horowitz, Casdin Capital, Section 32, Nextech and Arboretum Ventures.
Source: Press Release